Dr. Marco Cecchi, Neuronetrix’s Director of Research and Clinical Affairs.
Crystalline form of ANAVEX2-73 for the treatment of Alzheimer's disease
Abstract Composition and method for treatment of Alzheimer's disease that includes ANAVEX2-73. Method of treatment of Alzheimer's disease using pharmaceutical compositions comprising ANAVEX2-73 according to an intermittent dosage regimen.
Inventors: Cecchi; Marco (Louisville, KY) Applicant: Name City State Country Type
Anavex Life Sciences Corp. New York NY US Assignee: ANAVEX LIFE SCIENCES CORP. (New York, NY)